Ventas (FRA:VEN) Stock Based Compensation: €39 Mil (TTM As of Mar. 2026)


FRA:VEN Ventas Inc FRA:VEN
79 GF Score
Price €81.80
GF Value €60.04
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Ventas Stock Based Compensation?

Ventas FRA:VEN -0.37% 79 Stock Based Compensation is €39 Mil as of Mar. 2026. GuruFocus rates FRA:VEN with a GF Score™ of 79/100 and a GF Value™ of €60.04 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Ventas's Stock Based Compensation for the three months ended in Mar. 2026 was €21 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was €39 Mil.

Ventas Stock Based Compensation Related Terms

Ventas Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Ventas's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ventas Stock Based Compensation Chart

Ventas Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.29 29.00 28.42 29.60 33.08

Ventas Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.42 6.66 5.03 5.40 21.49
FRA:VEN
79GF Score
Ventas Inc FRA:VEN
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ventas Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €39 Mil.

What does a Stock Based Compensation of €39 Mil mean?
Ventas (FRA:VEN) has a Stock Based Compensation of €39 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ventas and its competitors.
Is Ventas' Stock Based Compensation too high?
Ventas' current Stock Based Compensation is €39 Mil. Overall, Ventas has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ventas' Stock Based Compensation compare to DOC and OHI?
Ventas' Stock Based Compensation of €39 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a REITs company?
A good Stock Based Compensation depends on the REITs industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ventas and its competitors. Ventas's current Stock Based Compensation is €39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ventas stock overvalued right now?
Based on GuruFocus' analysis, Ventas (FRA:VEN) is currently considered Significantly Overvalued. The stock's GF Value™ is €60.04, compared to a current price of €81.80 — trading 36.2% above its estimated fair value. The current Stock Based Compensation is €39 Mil. Ventas' overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Ventas (FRA:VEN), the current Stock Based Compensation is €39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ventas (FRA:VEN) Overvalued in 2026?

Based on GuruFocus' analysis, Ventas stock appears to be overvalued. The current stock price of €81.80 is trading 36.2% above its estimated GF Value™ of €60.04. GuruFocus considers Ventas to be Significantly Overvalued.

Key valuation signals for FRA:VEN:

  • Stock Based Compensation: €39 Mil
  • GF Value™: €60.04 vs. price of €81.80 (36.2% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the FRA:VEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ventas Business Description

Industry Real EstateREITs
Address 300 North LaSalle Street, Suite 1600, Chicago, IL, USA, 60654
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
79GF Score

Get the complete analysis for FRA:VEN

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€81.80
Price
€60.04
GF Value